2Pontet F. A data base for 3000 monoclonal immunoglobu- lin cases and a new classiticationLJ]. Clin Cbim Aeta, 2005,355(1/2) : 13-21.
3Anguille S, Bryant C. Monoclonal gammopathy of unde- termined signifieance[J]. CMAJ, 2013,185 (15): 1345.
4Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1)
5S. VincentRajkumar.Multiple myeloma: 2011 update on diagnosis, risk‐stratification, and management[J]. Am. J. Hematol. . 2010 (1)
6Maria Roussou,Efstathios Kastritis,Magdalini Migkou,Erasmia Psimenou,Irini Grapsa,Charis Matsouka,Despina Barmparousi,Evangelos Terpos,Meletios Athanasios Dimopoulos.Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens[J]. Leukemia & Lymphoma . 2008 (5)
7Jennifer M.Bird,RhianFuge,BhawnaSirohi,Jane F.Apperley,AnnHunter,JohnSnowden,PreminiMahendra,DonaldMilligan,JennyByrne,TimothyLittlewood,ChristopherFegan,GrantMcQuaker,AntonioPagliuca,PeterJohnson,AminRahemtulla,CurlyMorris,David I.Marks.The clinical outcome and toxicity of high‐dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study[J]. British Journal of Haematology . 2006 (4)
